LAPF和CD11b负向调控天然免疫应答及其机制研究
[Abstract]:The natural immune response is the first line of defense for the organism to resist the invasion of pathogenic microbes. However, the excessive activation of natural immune response can lead to the injury of the tissues and organs, which can lead to the production of autoimmune diseases and even cause the death of the patients. Therefore, the natural immune response should be activated in time to effectively remove the invading pathogens. The degree and duration of answer should also be controlled in a moderate range to maintain the balance of the body. It can be seen that the negative regulation of natural immune response is crucial to the maintenance of immune self stability. In recent years, the discovery and study of cells and molecules that can negatively regulate natural immunity gradually become the forefront of the field of natural immune research. Around the role of two negative regulators and related mechanisms, two parts of the negative regulation of natural immune response and its mechanism are carried out, including "LAPF inhibition of TLR triggering macrophages to produce TNF- alpha and its mechanism research" and "CD11b-Src signaling pathway to promote the production and mechanism of M2 macrophages", with a view to through our research To deepen the understanding and understanding of natural immune regulation and immune self stability. Part 1 LAPF inhibits TLR triggering macrophages to produce TNF-a and its mechanism, which includes PH and FYVE domain lysosome related apoptosis induced protein LAPF (also called PLEKHF1) which is by random large-scale sequencing from human dendritic cell cDNA library. A new lysosome related protein is now reported to be involved in the apoptosis of tumor cells induced by TNF-a in 2005. However, the function of LAPF in natural immunity has not been studied. In this subject, we prepared the LAPF deficient mice (lapfloxp/loxplyz2Cre/+), and found that the LAPF condition deficient mice were compared to the heterozygote control mice. The secretion of inflammatory cytokines increased in the endotoxin shock model, in which TNF- alpha was increased significantly, while the mRNA level of TNF- a in the lungs and spleen also increased significantly, suggesting that LAPF may negatively regulate the natural immune response and inflammation. Through in vitro cell experiments, it was found that the LAPF deficient macrophages secreted the increase of TNF- alpha under the TLR ligand stimulation. And TAK-, the activation level of phosphorylation of IKKa/ beta and p65 significantly increased, indicating that LAPF could inhibit the activation of NF- kappa B signaling pathway. Using Ip- mass spectrometry analysis and in vitro IP validation, we found that LAPF can be combined with TIRAP and MyD88 with TLR signal key transporter protein, which can further study the regulation of inflammatory cells and affect inflammatory cells. Factor release lays the foundation. Second CDllb-Src signaling pathway promotes the production and mechanism of M2 type macrophages. The regulation of integrin signal for natural immune response has been a hot issue in the frontier of natural immunity. Integrin has a very important role in the differentiation, development, migration, adhesion and activation of natural immune cells. CDllb is the a chain of integrin Mac-1, and CDllb antibodies are often used to screen out macrophages or other myeloid mononuclear phagocytes. Macrophages can be divided into M1 type (classic activated) macrophages and M2 type macrophages based on the phenotype and function of the macrophages, which release proinflammatory cytokines, respectively. The balance between M1 and M2 macrophages is essential for the regulation and self stability of natural immunity. In our laboratory, we have found that CDllb can degrade MyD88 and TRIF through Src-Syk ubiquitination, thus inhibiting the production of TNF-a in natural immune processes. However, CD11b-Src is in the phenotype and function of M1 and M2 in macrophages. The effect was not clear and worthy of further study. In the model of in vitro induced enteritis, we found that the CD1lb deficient mice and the mice treated with the Src inhibitor Dasatinib intraperitoneally were more severe in the colon, and the production of TNF-a in the mice was increased but the production of IL-10 decreased, and the expression of iNOS was enhanced but the expression of Arg-1 was enhanced. Weakened.TNF-a and iNOS are marker molecules of M1 type macrophages, IL-10 and Arg1 are marker molecules of M2 macrophages. This phenomenon suggests that CD11b-Src signals may induce macrophages to tend to M2 type macrophages. To this end, we directly detected the macrophages in the colon of mice that were treated with Dasatinib and induced enteritis. The proportion of M1 type macrophages increased and the proportion of M2 type macrophages decreased. Then we carried out CD11b-Src to make macrophages more inclined to M2 macrophage related mechanisms, and found that CD11b-Src in bone marrow derived macrophages can inhibit the expression of the M1 type macrophage marker molecule iNOS, which is induced by IFN- gamma, and CD11b-Src also can be used. Promote the expression of IL-4 induced M2 macrophage markers Arg-1 and YM-1; 2) CDllb promotes TLR induced STAT6 activation and IL-10 release by promoting the activation of Src-Akt signaling pathway. Further mechanism studies found that Src enhances Akt and activation of IL-4 signaling pathways, both of which are reported to promote macrophages. The expression of phenotypic molecules. However, only overexpression of STAT6 can reverse the downregulation of Src inhibitors to Argl, suggesting the important role of STAT6 in this process,.Src can interact with STAT6 to form a complex, and further hints that Src can participate in activated STAT6. in the TLR signal stimulation, Src by promoting P13K to regulate the ubiquitin of subunit p85. Degradation, promoting activation of PI3K-Akt signaling pathway, and further promoting the activation of AP-1 through negative regulation of GSK, eventually promotes the production of IL-10. In conclusion, CD11b-Src makes macrophages more likely to be M2 type macrophages by promoting STAT6 and Akt activation. Thus, CD11b-Src has an important role in natural immune negative regulation and control of inflammation. Studying the mechanism of CD11b-Src will help us to further understand the occurrence and development of inflammation and the research and development of anti-inflammatory drugs.
【学位授予单位】:北京协和医学院
【学位级别】:博士
【学位授予年份】:2016
【分类号】:R392
【相似文献】
相关期刊论文 前10条
1 ;豚鼠巨噬细胞经P_(204)处理后的抗石英细胞毒作用[J];国外医学参考资料(卫生学分册);1976年04期
2 邓侠进;;巨噬细胞的抗癌作用[J];遵义医学院学报;1979年02期
3 陆天才;;疾病对肺巨噬细胞的影响[J];煤矿医学;1982年01期
4 郭瑞清;祝彼得;;一种分离巨噬细胞的简单方法[J];滨州医学院学报;1990年02期
5 谢志坚;巨噬细胞异质性[J];医学综述;2001年06期
6 饶艳;运动及神经内分泌对巨噬细胞功能的调节[J];体育与科学;2002年05期
7 朱金元;;吸烟对肺巨噬细胞的影响[J];浙江医学教育;2003年01期
8 张俊峰;过氧化物酶体增殖物激活受体与单核/巨噬细胞系[J];医学综述;2004年03期
9 韦锦学;顾军;;巨噬细胞的激活诱导死亡[J];生命科学;2006年02期
10 李晓曦;郭宁;曹雪涛;;肿瘤相关巨噬细胞促进肿瘤生长与转移的研究现状[J];中国肿瘤生物治疗杂志;2008年01期
相关会议论文 前10条
1 史玉玲;王又明;丰美福;;巨噬细胞激活作用的研究[A];中国细胞生物学学会第五次会议论文摘要汇编[C];1992年
2 吴国明;周辉;;巨噬细胞和创伤纤维化[A];2009年浙江省骨科学学术年会论文汇编[C];2009年
3 李奇;王海杰;;透明质酸对于淋巴结巨噬细胞运动的影响[A];解剖学杂志——中国解剖学会2002年年会文摘汇编[C];2002年
4 刘革修;欧大明;刘军花;黄红林;廖端芳;;丙丁酚在体外能抑制巨噬细胞脂质氧化介导的低密度脂蛋白氧化并调节氧化巨噬细胞的分泌功能[A];面向21世纪的科技进步与社会经济发展(下册)[C];1999年
5 叶金善;杨丽霞;郭瑞威;;环氧化酶-2/前列腺素E_2在血管紧张素Ⅱ刺激巨噬细胞表达细胞外基质金属蛋白酶诱导因子中的作用[A];第十三次全国心血管病学术会议论文集[C];2011年
6 秦帅;陈希;孔德明;;构建由绿色荧光标记巨噬细胞的转基因斑马鱼系[A];贵州省中西医结合内分泌代谢学术会论文汇编[C];2012年
7 武剑华;徐惠绵;;肿瘤相关巨噬细胞在胃癌中的相关研究[A];第9届全国胃癌学术会议暨第二届阳光长城肿瘤学术会议论文汇编[C];2014年
8 何军;;血凝素样氧化型低密度脂蛋白受体升高巨噬细胞内胆固醇水平[A];中华医学会第11次心血管病学术会议论文摘要集[C];2009年
9 宋盛;周非凡;邢达;;PDT诱导的凋亡细胞对巨噬细胞NO合成的影响[A];第七届全国光生物学学术会议论文摘要集[C];2010年
10 张磊;朱建华;黄元伟;姚航平;;血管紧张素Ⅱ对巨噬细胞(THP-1重细胞)凝集素样氧化低密度脂蛋白受体表达的影响[A];浙江省免疫学会第五次学术研讨会论文汇编[C];2004年
相关重要报纸文章 前10条
1 通讯员 李静 记者 胡德荣;恶性肿瘤巨噬细胞未必皆“恶人”[N];健康报;2014年
2 兰克;以尝试用巨噬细胞治瘫痪[N];科技日报;2000年
3 薛佳;免疫系统——人体的“卫士”[N];保健时报;2009年
4 记者 胡德荣;铁泵蛋白“维稳”铁代谢作用首次阐明[N];健康报;2011年
5 侯嘉 何新乡;硒的神奇功能[N];中国食品质量报;2003年
6 唐颖 倪兵 陈代杰;巨噬细胞泡沫化抑制剂研究快步进行[N];中国医药报;2006年
7 刘元江;新发现解释肿瘤为何易成“漏网之鱼”[N];医药经济报;2007年
8 本报记者 侯嘉 通讯员 何新乡;今天你补硒了吗[N];医药经济报;2003年
9 左志刚;升血小板药使用注意[N];医药养生保健报;2007年
10 记者 许琦敏;“铁泵”蛋白帮助回收铁元素[N];文汇报;2011年
相关博士学位论文 前10条
1 周赤燕;巨噬细胞MsrA对动脉粥样硬化的干预研究[D];武汉大学;2013年
2 章桂忠;TIPE2蛋白调控细胞增殖和炎症的机制研究[D];山东大学;2015年
3 张瑜;DKK1抑制巨噬细胞内脂质沉积及其相关分子机制[D];山东大学;2015年
4 孟涛;异丙酚对心脏收缩功能的抑制作用及其对巨噬细胞分泌功能调节的机制研究[D];山东大学;2015年
5 周兴;基于酵母微囊构建新型口服巨噬细胞靶向递送系统的研究[D];第三军医大学;2015年
6 蒋兴伟;Tim-3对巨噬细胞极化的调控机制研究[D];中国人民解放军军事医学科学院;2015年
7 刘伯玉;清道夫受体A介导小鼠巨噬细胞吞噬钩端螺旋体研究[D];上海交通大学;2013年
8 杨绍俊;miRNA-155介导ESAT-6诱导巨噬细胞凋亡的分子机制及其在结核诊断中的作用[D];第三军医大学;2015年
9 翟光耀;单核/巨噬细胞Ly6C~(low)亚群在心肌梗死后瘢痕形成期的抗炎特性研究[D];北京协和医学院;2014年
10 韩露;TRB3介导的脂肪组织巨噬细胞极化与糖尿病冠状动脉病变关系的研究[D];山东大学;2015年
相关硕士学位论文 前10条
1 张译丹;盐皮质激素受体拮抗剂调控巨噬细胞表型对实验性矽肺的作用[D];河北医科大学;2015年
2 卢文冉;HCV core蛋白作用的巨噬细胞培养上清对肝细胞生物学性状的影响[D];河北医科大学;2015年
3 李文建;载脂蛋白E影响巨噬细胞因子表达及分型的机制研究[D];河北医科大学;2015年
4 曹爽;高糖对巨噬细胞TLR4信号转导的调节作用[D];河北医科大学;2015年
5 宁程程;肿瘤相关巨噬细胞在子宫内膜癌雌激素敏感性中的作用及机制研究[D];复旦大学;2014年
6 高龙;PLD4在肿瘤相关巨噬细胞抑制结肠癌增殖中的作用研究[D];成都医学院;2015年
7 丁弋娜;TLR4在肺癌相关巨噬细胞极性转化及其调控机制的研究[D];杭州师范大学;2016年
8 袁震;砷对巨噬细胞和肝细胞胆固醇流出及相关基因ABCA1和ABCG1表达的影响[D];杭州师范大学;2016年
9 李晓琴;Fc99抑制单核/巨噬细胞表达Tenascin-C及缓解关节炎症状的研究[D];南京大学;2014年
10 王凯凯;绿豆肽的结构鉴定及对小鼠巨噬细胞免疫活性物质的影响作用研究[D];黑龙江八一农垦大学;2016年
,本文编号:2152766
本文链接:https://www.wllwen.com/yixuelunwen/jichuyixue/2152766.html